ODDB.org: Open Drug Database

Labatec Pharma SA - Irinotecan Labatec 300 mg/15 ml, solution à diluer pour perfusion

Swissmedic Registration	59284	Sequence	03
Product name	Irinotecan Labatec 300 mg/15 ml	Description	solution à diluer pour perfusion
ATC-Classification	L01XX19	ATC-Description	Irinotecan
Introduction of Sequence	15.03.2012

Composition

irinotecani hydrochloridum trihydricum 300 mg, sorbitolum 675 mg, acidum lacticum, acidum hydrochloricum q.s. ad pH, natrii hydroxidum q.s. ad pH, aqua ad iniectabile ad solutionem pro 15 ml corresp. natrium 34.49 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	300 mg

BAG: Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	300 mg

Inactive agents	Dose
Hydrochloric Acid
Lactic Acid
Sorbitol	675 mg

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003	Durchstechflasche(n)	245.64	283.55	A	SL	No

2026	©ywesee GmbH